The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 45.26% this year. Over the last six months, there has been a weaker performance of 49.19%. The price of AKBA fallen by 64.29% during the last 30 days period. For the last 5-days stocks have improved 15.48%.
Akebia Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $2.89 on 05/08/25, while the lowest price for the same period was registered at $0.80 on 06/26/24.
52-week price history of AKBA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Akebia Therapeutics Inc’s current trading price is -4.50% away from its 52-week high, while its distance from the 52-week low is 245.00%. The stock’s price range during this time has been between $0.80 and $2.89. The trading volume for the Healthcare sector company’s shares reached about 6.09 million for the day, which was higher than the average daily volume of 4.14 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Akebia Therapeutics Inc (AKBA) has experienced a quarterly rise of 27.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 722.53M and boasts a workforce of 181 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.03, with a change in price of +0.75. Similarly, Akebia Therapeutics Inc recorded 3,441,697 in trading volume during the last 100 days, posting a change of +39.32%.
AKBA Stock Stochastic Average
Today, Akebia Therapeutics Inc’s raw stochastic average for the past 50 days stands at 83.70%, indicating a rise from the raw stochastic average of the last 20 days, which was 83.70%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 88.32% and 88.58% respectively.
